Epigenetic Control of CD8 T Cell Differentiation

Overview

Journal Nat Rev Immunol

Specialty Allergy & Immunology

Date 2018 Jan 31

PMID 29379213

Citations 259

Authors

Amanda N Henning

Rahul Roychoudhuri

Nicholas P Restifo

Affiliations

Soon will be listed here.

Abstract

Upon stimulation, small numbers of naive CD8 T cells proliferate and differentiate into a variety of memory and effector cell types. CD8 T cells can persist for years and kill tumour cells and virally infected cells. The functional and phenotypic changes that occur during CD8 T cell differentiation are well characterized, but the epigenetic states that underlie these changes are incompletely understood. Here, we review the epigenetic processes that direct CD8 T cell differentiation and function. We focus on epigenetic modification of DNA and associated histones at genes and their regulatory elements. We also describe structural changes in chromatin organization that affect gene expression. Finally, we examine the translational potential of epigenetic interventions to improve CD8 T cell function in individuals with chronic infections and cancer.

Citing Articles

The epigenetic hallmarks of immune cells in cancer.

Ji Y, Xiao C, Fan T, Deng Z, Wang D, Cai W Mol Cancer. 2025; 24(1):66.

PMID: 40038722 PMC: 11881328. DOI: 10.1186/s12943-025-02255-4.

Plasma Exosomes Derived from Patients with Primary Immune Thrombocytopenia Attenuate TBX21 Regulatory T Cell-Mediated Immune Suppression via MiR-363-3p.

Huang Y, Liu P, Xu Y, Qian C, Wu T, Li T Inflammation. 2025; .

PMID: 40032779 DOI: 10.1007/s10753-025-02275-8.

Epigenetic modifications in bladder cancer: crosstalk between DNA methylation and miRNAs.

Li W, Luo P, Chen Q, Cheng L, Gan L, Zhang F Front Immunol. 2025; 16:1518144.

PMID: 39981244 PMC: 11841399. DOI: 10.3389/fimmu.2025.1518144.

Outcome correlates of approved CD19-targeted CAR T cells for large B cell lymphoma.

Bock T, Colonne C, Fiorenza S, Turtle C Nat Rev Clin Oncol. 2025; .

PMID: 39966627 DOI: 10.1038/s41571-025-00992-5.

Exploring viral mimicry combined with epigenetics and tumor immunity: new perspectives in cancer therapy.

Wang R, Dong X, Zhang X, Liao J, Cui W, Li W Int J Biol Sci. 2025; 21(3):958-973.

PMID: 39897033 PMC: 11781167. DOI: 10.7150/ijbs.103877.

References

Ladle B, Li K, Phillips M, Pucsek A, Haile A, Powell J . De novo DNA methylation by DNA methyltransferase 3a controls early effector CD8+ T-cell fate decisions following activation. Proc Natl Acad Sci U S A. 2016; 113(38):10631-6. PMC: 5035851. DOI: 10.1073/pnas.1524490113. View

Zhao E, Maj T, Kryczek I, Li W, Wu K, Zhao L . Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction. Nat Immunol. 2015; 17(1):95-103. PMC: 4684796. DOI: 10.1038/ni.3313. View

Pradeepa M, Sutherland H, Ule J, Grimes G, Bickmore W . Psip1/Ledgf p52 binds methylated histone H3K36 and splicing factors and contributes to the regulation of alternative splicing. PLoS Genet. 2012; 8(5):e1002717. PMC: 3355077. DOI: 10.1371/journal.pgen.1002717. View

He S, Liu Y, Meng L, Sun H, Wang Y, Ji Y . Ezh2 phosphorylation state determines its capacity to maintain CD8 T memory precursors for antitumor immunity. Nat Commun. 2017; 8(1):2125. PMC: 5730609. DOI: 10.1038/s41467-017-02187-8. View

Gattinoni L, Klebanoff C, Palmer D, Wrzesinski C, Kerstann K, Yu Z . Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells. J Clin Invest. 2005; 115(6):1616-26. PMC: 1137001. DOI: 10.1172/JCI24480. View

Barber D, Wherry E, Masopust D, Zhu B, Allison J, Sharpe A . Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. 2005; 439(7077):682-7. DOI: 10.1038/nature04444. View

Jeong K, Kim K, Situ A, Ulmer T, An W, Stallcup M . Recognition of enhancer element-specific histone methylation by TIP60 in transcriptional activation. Nat Struct Mol Biol. 2011; 18(12):1358-65. PMC: 3230772. DOI: 10.1038/nsmb.2153. View

Doering T, Crawford A, Angelosanto J, Paley M, Ziegler C, Wherry E . Network analysis reveals centrally connected genes and pathways involved in CD8+ T cell exhaustion versus memory. Immunity. 2012; 37(6):1130-44. PMC: 3749234. DOI: 10.1016/j.immuni.2012.08.021. View

Branco M, Ficz G, Reik W . Uncovering the role of 5-hydroxymethylcytosine in the epigenome. Nat Rev Genet. 2011; 13(1):7-13. DOI: 10.1038/nrg3080. View

10.

Ktistaki E, Garefalaki A, Williams A, Andrews S, Bell D, Foster K . CD8 locus nuclear dynamics during thymocyte development. J Immunol. 2010; 184(10):5686-95. DOI: 10.4049/jimmunol.1000170. View

11.

Shin M, You S, Kang Y, Lee N, Yoo S, Park K . DNA Methylation Regulates the Differential Expression of CX3CR1 on Human IL-7Rαlow and IL-7Rαhigh Effector Memory CD8+ T Cells with Distinct Migratory Capacities to the Fractalkine. J Immunol. 2015; 195(6):2861-9. PMC: 4561204. DOI: 10.4049/jimmunol.1500877. View

12.

Kato K, Cui S, Kuick R, Mineishi S, Hexner E, Ferrara J . Identification of stem cell transcriptional programs normally expressed in embryonic and neural stem cells in alloreactive CD8+ T cells mediating graft-versus-host disease. Biol Blood Marrow Transplant. 2010; 16(6):751-71. PMC: 2913321. DOI: 10.1016/j.bbmt.2010.01.012. View

13.

Ghoneim H, Fan Y, Moustaki A, Abdelsamed H, Dash P, Dogra P . De Novo Epigenetic Programs Inhibit PD-1 Blockade-Mediated T Cell Rejuvenation. Cell. 2017; 170(1):142-157.e19. PMC: 5568784. DOI: 10.1016/j.cell.2017.06.007. View

14.

Losman J, Kaelin Jr W . What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer. Genes Dev. 2013; 27(8):836-52. PMC: 3650222. DOI: 10.1101/gad.217406.113. View

15.

Mognol G, Spreafico R, Wong V, Scott-Browne J, Togher S, Hoffmann A . Exhaustion-associated regulatory regions in CD8 tumor-infiltrating T cells. Proc Natl Acad Sci U S A. 2017; 114(13):E2776-E2785. PMC: 5380094. DOI: 10.1073/pnas.1620498114. View

16.

Ing-Simmons E, Seitan V, Faure A, Flicek P, Carroll T, Dekker J . Spatial enhancer clustering and regulation of enhancer-proximal genes by cohesin. Genome Res. 2015; 25(4):504-13. PMC: 4381522. DOI: 10.1101/gr.184986.114. View

17.

Blackburn S, Shin H, Freeman G, Wherry E . Selective expansion of a subset of exhausted CD8 T cells by alphaPD-L1 blockade. Proc Natl Acad Sci U S A. 2008; 105(39):15016-21. PMC: 2567485. DOI: 10.1073/pnas.0801497105. View

18.

Pastor W, Aravind L, Rao A . TETonic shift: biological roles of TET proteins in DNA demethylation and transcription. Nat Rev Mol Cell Biol. 2013; 14(6):341-56. PMC: 3804139. DOI: 10.1038/nrm3589. View

19.

Duraiswamy J, Freeman G, Coukos G . Therapeutic PD-1 pathway blockade augments with other modalities of immunotherapy T-cell function to prevent immune decline in ovarian cancer. Cancer Res. 2013; 73(23):6900-12. PMC: 3851914. DOI: 10.1158/0008-5472.CAN-13-1550. View

20.

Rao S, Huntley M, Durand N, Stamenova E, Bochkov I, Robinson J . A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell. 2014; 159(7):1665-80. PMC: 5635824. DOI: 10.1016/j.cell.2014.11.021. View